Le Clair Wealth Partners LLC Abb Vie Inc. Transaction History
Le Clair Wealth Partners LLC
- $147 Billion
- Q2 2025
A detailed history of Le Clair Wealth Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Le Clair Wealth Partners LLC holds 1,425 shares of ABBV stock, worth $323,289. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,425
Previous 1,422
0.21%
Holding current value
$323,289
Previous $298 Million
11.22%
% of portfolio
0.18%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,324Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$40.2 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$31 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$18.2 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$12.4 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.46 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $401B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...